Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-099413

Adverum Biotechnologies, Inc. · ADVM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Mehdi Gasmi
Officer — Chief Scientific Officer
Period of report
Feb 12, 2016
Accepted (ET)
Feb 17, 2016 · 5:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501756

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Feb 12, 2016A125,000$0.00A161,803D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F3$4.80Feb 12, 2016A188,000A—Feb 11, 2026Common Stock188,000188,000D

Explanation of responses